Laurence F. Morton
University of Cambridge
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Laurence F. Morton.
Cardiovascular Research | 1999
C. Graham Knight; Laurence F. Morton; David J. Onley; A.R. Peachey; Tatsuo Ichinohe; Minoru Okuma; Richard W. Farndale; Michael J. Barnes
OBJECTIVE Peptides consisting of a repeat Gly-Pro-Hyp sequence are potent platelet agonists. The aim of this study was: (1) to examine the specificity of this sequence for platelet activation; (2) to confirm its recognition by platelet glycoprotein VI; and (3) to assess with suitable peptides the relative importance of glycoprotein VI and integrin alpha 2 beta 1 in platelet activation by collagen. METHODS Peptides were synthesized by standard Fmoc chemistry and tested for their ability to support adhesion of human platelets and HT 1080 cells, induce platelet aggregation, bind integrin alpha 2 subunit A-domain and to cause tyrosine phosphorylation of platelet proteins. RESULTS (1) Peptides consisting of a repeat Gly-Pro-Pro, Gly-Pro-Ala or Gly-Pro-Arg sequence exhibited little if any platelet-reactivity. (2) The platelet-reactive peptide consisting of a repeating Gly-Pro-Hyp sequence failed to induce tyrosine phosphorylation in glycoprotein VI-deficient platelets. Platelet adhesion to this peptide was inhibited by intact anti-glycoprotein VI antibody and its Fab fragment. The latter inhibited aggregation by the peptide and fibres of both collagens I and III. (3) A peptide containing a 15-mer alpha 2 beta 1-binding sequence in a repeat Gly-Pro-Pro structure supported alpha 2 beta 1-mediated platelet and HT 1080 cell adhesion and bound alpha 2 A-domain, but failed to activate platelets or to induce tyrosine phosphorylation. Conversely, a peptide containing this sequence but with an essential Glu replaced by Ala and inserted in a repeat Gly-Pro-Hyp structure did not recognize alpha 2 beta 1, but was highly platelet activatory. CONCLUSIONS Platelet activation by collagen involves the highly-specific recognition of the Gly-Pro-Hyp sequence by platelet glycoprotein VI. Recognition of alpha 2 beta 1 is insufficient to cause activation. Interaction between collagen and glycoprotein VI is unique since Gly-Pro-Hyp is common in collagens but occurs rarely in other proteins, and glycoprotein VI may be expressed solely by platelets. This sequence could provide a basis for a highly-specific anti-thrombotic reagent to control thrombosis associated with plaque rupture.
Journal of Biological Chemistry | 1997
Laurence F. Morton; Anthony R. Peachey; Knight Cg; Richard W. Farndale; Mike Barnes
The platelet-reactive collagen III-derived fragment α1(III)CB4 has been synthesized as seven overlapping peptides, each as a homotrimeric triple-helical species covalently linked at the C terminus. Additional Gly-Pro-Hyp triplets were introduced at each end of the peptide sequence to ensure a stable triple-helical conformation at 20°C, the temperature at which cell reactivity was measured. A Cys-containing triplet was included at each end to allow intermolecular cross-linking. All seven peptides in triple-helical, cross-linked form were able to cause platelet aggregation. Peptide 6, the most reactive species, was more aggregatory than collagen fibers. Platelet adhesion occurred to all peptides immobilized on plastic in monomeric form. Adhesion was integrin α2β1-independent except in the case of peptide 6, adhesion to which was partially reduced by anti-integrin α2β1 monoclonal antibodies. The presence of an α2β1 recognition site in peptide 6 was confirmed using HT 1080 cells, which express α2β1 as their major or sole collagen receptor. HT 1080 adhesion to both peptide 6 and collagen was strongly inhibited by anti-integrin α2β1 monoclonal antibodies. These cells did not adhere to any of the other peptides. Comparison of the structure of peptide 6 with that of adjacent peptides indicates that the sequence Gly-Gly-Pro-Hyp-Gly-Pro-Arg, residues 522-528 of the collagen α1(III) chain, represents the minimum structure required for the recognition of α2β1. Our findings support the view that the collagen triple helix possesses an intrinsic platelet reactivity that can be expressed independently of integrin α2β1 and the precise level of which is governed by the exact nature of the primary sequence. Sequences such as those recognizing α2β1 may potentiate the activity, whereas others may have the opposite effect.
Journal of Biological Chemistry | 1996
J Saklatvala; Lesley Rawlinson; Richard J. Waller; Simon J. Sarsfield; John C. Lee; Laurence F. Morton; Mike Barnes; Richard W. Farndale
Blood | 1997
Judith Asselin; Jonathan M. Gibbins; Marcus Achison; Young Han Lee; Laurence F. Morton; Richard W. Farndale; Mike Barnes; Steve P. Watson
Blood | 1998
Marilyn W. Verkleij; Laurence F. Morton; C. Graham Knight; Philip G. de Groot; Mike Barnes; Jan J. Sixma
Thrombosis Research | 1993
Laurence F. Morton; Isobel Y. McCulloch; Mike Barnes
Thrombosis and Haemostasis | 1999
Marilyn W. Verkleij; Martin J. W. IJsseldijk; Glenda J. Heijnen-Snyder; Eric G. Huizinga; Laurence F. Morton; C. Graham Knight; Jan J. Sixma; Philip G. de Groot; Mike Barnes
Collagen and related research | 1985
Laurence F. Morton; Robert D. Young; Mike Barnes
Biochemical Society Transactions | 1991
Laurence F. Morton; Zijenah Ls; McCulloch Iy; Knight Cg; Martin J. Humphries; Michael J. Barnes
Archive | 2010
Jan J. Sixma; Marilyn W. Verkleij; Laurence F. Morton; C. Graham Knight; Phillip G. de Groot; Michael J. Barnes